Vimarsana
Biggest News Aggregation in the World

Christoph Ganss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christoph Ganss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christoph Ganss Today - Breaking & Trending Today

Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease' - Vimarsana News

Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease'

Source: prleap.com
RHEACELL announces "First Patient In": EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy - Vimarsana News

RHEACELL announces "First Patient In": EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy

RHEACELL announces "First Patient In": EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected

Source: prleap.com
Stem cell therapy for "Butterfly disease" / RHEACELL receives 'Partners in Progress Award' from debra of America for Epidermolysis Bullosa research - Vimarsana News

Stem cell therapy for "Butterfly disease" / RHEACELL receives 'Partners in Progress Award' from debra of America for Epidermolysis Bullosa research

Heidelberg, November 9, 2022. The biopharmaceutical company RHEACELL, which specializes in stem cells, was honored on October 24 by the organization 'Dystrophic Epidermolysis Bullosa Research Association of America' (debra) with the 'Partners in Progress Award'.

Source: prleap.com
RHEACELL GmbH & Co. KG: From Chronic to Curable? RHEACELL is Developing a Novel Cell-Therapy Agent for the Treatment of Chronic Venous Ulcers - Vimarsana News

RHEACELL GmbH & Co. KG: From Chronic to Curable? RHEACELL is Developing a Novel Cell-Therapy Agent for the Treatment of Chronic Venous Ulcers

HEIDELBERG, GERMANY / ACCESSWIRE / October 19, 2021 / Heidelberg-based biopharmaceutical company is conducting a follow-up study with highly purified stem cells (AMESANAR (R) ) for the treatment of previously

Germany Approves Novel Cell Therapy Extracted from Skin - Vimarsana News

Germany Approves Novel Cell Therapy Extracted from Skin

Germany Approves Novel Cell Therapy Extracted from Skin - read this article along with other careers information, tips and advice on BioSpace